Numerous investigators have found that as much as 75% of the hyperinsulinemia in obese, insulin resistant patients, appeared to be the result of decreased hepatic insulin clearance [44–47], a phenomenon also noted in dysmetabolic monkeys [48]. The gene discussed is INS; the disease is hyperinsulinism.